From: Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor
Kinase
Compound 1 IC50(nM)
Compound 2 IC50(nM)
Tyk2
6 ± 1
<3 (N = 4)
Jak1
5 ± 0.4
10 ± 0.1
Jak2
7 ± 2
4 ± 1
Jak3
42 ± 1
41 ± 3